All Stories

  1. Comparison of Efficiency and Side Effects of Daily and Alternate Day Oral Iron

    Article • July 2023, MDPI AG

    Dr Umit Yavuz Malkan

  2. Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874

    Article • Medicina, November 2022, MDPI AG

    Dr Umit Yavuz Malkan

  3. A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura

    Article • Case Reports in Oncology, November 2020, Karger Publishers

    Dr Umit Yavuz Malkan

  4. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis

    Article • Journal of Oncology Pharmacy Practice, June 2020, SAGE Publications

    Dr Umit Yavuz Malkan

  5. In vitro analysis of the renin–angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus

    Article • Journal of the Renin-Angiotensin-Aldosterone System, April 2020, SAGE Publications

    Dr Umit Yavuz Malkan

  6. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)

    Article • SAGE Open Medicine, January 2020, SAGE Publications

    Dr Umit Yavuz Malkan

  7. Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead Of Hepatitis C Virus As An Etiologic and Possible Prognostic Factor-Multicenter Cohort Study

    Article • Turkish Journal of Hematology, October 2019, Journal of Clinical Research of Pediatric Endocrinology

    Dr Umit Yavuz Malkan

  8. The factors affecting early death in newly diagnosed APL patients

    Article • Open Medicine, September 2019, De Gruyter

    Rafiye Ciftciler, Dr Umit Yavuz Malkan

  9. The impact of early versus late platelet and neutrophil recovery after induction chemotherapy on survival outcomes of patients with acute myeloid leukemia

    Article • Turkish Journal of Hematology, September 2019, Journal of Clinical Research of Pediatric Endocrinology

    Dr Umit Yavuz Malkan

  10. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

    Article • TURKISH JOURNAL OF MEDICAL SCIENCES, August 2019, The Scientific and Technological Research Council of Turkey

    Dr Umit Yavuz Malkan

  11. Indications and outcomes of splenectomy for hematological disorders

    Article • Open Medicine, June 2019, De Gruyter

    Rafiye Ciftciler, Dr Umit Yavuz Malkan

  12. The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia

    Article • Journal of the Renin-Angiotensin-Aldosterone System, April 2019, SAGE Publications

    Dr Umit Yavuz Malkan

  13. Fibrosis Development, Leukemic Transformation and Secondary Malignancies Complicating the Clinical Course of Essential Thrombocythemia

    Article • International Journal of Hematology and Oncology, March 2019, Akademi Doktorlar Yayinevi

    Dr Umit Yavuz Malkan

  14. Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia

    Article • Clinical Lymphoma Myeloma & Leukemia, March 2019, Elsevier

    Dr Umit Yavuz Malkan

  15. Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia

    Article • International Journal of Hematology and Oncology, December 2018, Akademi Doktorlar Yayinevi

    Dr Umit Yavuz Malkan

  16. Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia

    Article • Open Medicine, December 2018, De Gruyter

    Dr Umit Yavuz Malkan

  17. Combination of novoseven and feiba in hemophiliac patients with inhibitors

    Article • Open Medicine, December 2018, De Gruyter

    Dr Umit Yavuz Malkan

  18. Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients

    Article • Transfusion and Apheresis Science, December 2018, Elsevier

    Dr Umit Yavuz Malkan

  19. Immunosuppression-associated posterior reversible encephalopathy syndrome in an acute leukemia case

    Article • Hematology Reports, November 2018, PAGEPress Publications

    Dr Umit Yavuz Malkan

  20. Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors

    Article • Bone Marrow Transplantation, August 2018, Springer Science + Business Media

    Dr Umit Yavuz Malkan

  21. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis

    Article • Transfusion and Apheresis Science, December 2017, Elsevier

    Dr Umit Yavuz Malkan

  22. Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission

    Article • Turkish Journal of Hematology, March 2017, Journal of Clinical Research of Pediatric Endocrinology

    Dr Umit Yavuz Malkan

  23. Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines

    Article • SAGE Open Medicine, February 2017, SAGE Publications

    Dr Umit Yavuz Malkan

  24. Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

    Article • Blood, December 2016, American Society of Hematology

    Dr Umit Yavuz Malkan

  25. Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma

    Article • Turkish Journal of Hematology, December 2016, Journal of Clinical Research of Pediatric Endocrinology

    Dr Umit Yavuz Malkan

  26. The Prognosis of Adult Burkitt’s Cell Leukemia in Real-Life Clinical Practice

    Article • Turkish Journal of Hematology, December 2016, Journal of Clinical Research of Pediatric Endocrinology

    Dr Umit Yavuz Malkan

  27. Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level

    Article • SpringerPlus, November 2016, Springer Science + Business Media

    Dr Umit Yavuz Malkan

  28. Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis

    Article • Journal of International Medical Research, November 2016, SAGE Publications

    Dr Umit Yavuz Malkan

  29. The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases.

    Article • International Journal of Hematology and Oncology, September 2016, Akademi Doktorlar Yayinevi

    Dr Umit Yavuz Malkan

  30. Poster Session TPS 1-18

    Article • Allergy, August 2016, Wiley

    Dr Umit Yavuz Malkan

  31. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders.

    Article • International Journal of Hematology and Oncology, March 2016, Akademi Doktorlar Yayinevi

    Dr Umit Yavuz Malkan

  32. Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case

    Article • International Medical Case Reports Journal, March 2016, Dove Medical Press

    Dr Umit Yavuz Malkan

  33. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias.

    Article • International Journal of Hematology and Oncology, March 2016, Akademi Doktorlar Yayinevi

    Dr Umit Yavuz Malkan

  34. Reply

    Article • Annals of Pharmacotherapy, February 2016, SAGE Publications

    Dr Umit Yavuz Malkan

  35. Chimeric antigen receptor T cell treatment in hematologic malignancies

    Article • Transfusion and Apheresis Science, February 2016, Elsevier

    Dr Umit Yavuz Malkan

  36. Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids

    Article • BioMed Research International, January 2016, Hindawi Publishing Corporation

    Prof Nejat Akar, Dr Umit Yavuz Malkan

  37. Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML.

    Article • International Journal of Hematology and Oncology, December 2015, Akademi Doktorlar Yayinevi

    Dr Umit Yavuz Malkan

  38. Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers

    Article • SpringerPlus, October 2015, Springer Science + Business Media

    Dr Umit Yavuz Malkan

  39. Extramedullary relapses after allogeneic stem cell transplantation for leukemia: Clinical characteristics, cumulative incidence and risk factors.

    Article • Journal of Clinical Oncology, May 2015, American Society of Clinical Oncology (ASCO)

    Dr Umit Yavuz Malkan

  40. Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib

    Article • Annals of Pharmacotherapy, May 2015, SAGE Publications

    Dr Umit Yavuz Malkan

  41. Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

    Article • Acta Haematologica, April 2015, Karger Publishers

    Dr Umit Yavuz Malkan

  42. Erdheim-Chester Disease: A Case Report

    Article • American Journal of Case Reports, January 2015, International Scientific Literature

    Dr Umit Yavuz Malkan

  43. Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse

    Article • Case Reports in Medicine, January 2015, Hindawi Publishing Corporation

    Dr Umit Yavuz Malkan

  44. Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease

    Article • Case Reports in Hematology, January 2015, Hindawi Publishing Corporation

    Dr Umit Yavuz Malkan

  45. Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case

    Article • Case Reports in Hematology, January 2015, Hindawi Publishing Corporation

    Dr Umit Yavuz Malkan

  46. Giant Hemophilic Pseudotumor of the Iliopsoas: Case Report

    Article • International Journal of Hematology and Oncology, December 2014, Akademi Doktorlar Yayinevi

    Dr Umit Yavuz Malkan

  47. Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

    Article • Blood, December 2014, American Society of Hematology

    Dr Umit Yavuz Malkan

  48. Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

    Article • Blood, December 2014, American Society of Hematology

    Dr Umit Yavuz Malkan

  49. Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

    Article • Blood, December 2014, American Society of Hematology

    Dr Umit Yavuz Malkan

  50. PP-025 ADVANCED PHASE CHRONIC MYELOID LEUKEMIA RESISTANT TO IMATINIB, NILOTINIB, DASATINIB AND INTERFERON WITHOUT ABL KINASE MUTATION

    Article • Leukemia Research, October 2014, Elsevier

    Dr Umit Yavuz Malkan

  51. PP-020 AN ESSENTIAL THROMBOCYTOSIS CASE, WHICH TRANSFORMED TO ACUTE MYELOID LEUKEMIA AFTER 12 YEARS

    Article • Leukemia Research, October 2014, Elsevier

    Dr Umit Yavuz Malkan

  52. PP-021 ASHERMAN SYNDROME WITH FACTOR 7 DEFICIENCY: CASE REPORT

    Article • Leukemia Research, October 2014, Elsevier

    Dr Umit Yavuz Malkan

  53. PP-058 MYASTENIA GRAVIS AND WALDENSTROM MACROGLOBULINEMIA: IS COMMON IMMUNOLOGIC MECHANISM POSSIBLE?

    Article • Leukemia Research, October 2014, Elsevier

    Dr Umit Yavuz Malkan

  54. PP-063 TWO CASES WITH PRIMARY IMMUNE DEFICIENCY AND NEOPLASTIC LYMPHOID PROLIFERATION

    Article • Leukemia Research, October 2014, Elsevier

    Dr Umit Yavuz Malkan